Literature DB >> 35814886

Combined central retinal artery and vein occlusion associated with primary antiphospholipid syndrome treated by injection of dexamethasone intravitreal implant and anticoagulant therapy: a case report.

Bing-Wen Lu1, Li-Ke Xie1, Xiao-Feng Hao1, Xiao-Yan Zhang1, Jie Luo1.   

Abstract

Entities:  

Year:  2022        PMID： 35814886      PMCID： PMC9203466          DOI： 10.18240/ijo.2022.06.25

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN： 2222-3959            Impact factor:   1.645


× No keyword cloud information.
  8 in total

Review 1.  International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop.

Authors:  W A Wilson; A E Gharavi; T Koike; M D Lockshin; D W Branch; J C Piette; R Brey; R Derksen; E N Harris; G R Hughes; D A Triplett; M A Khamashta
Journal:  Arthritis Rheum       Date:  1999-07

2.  Value of autoantibodies to beta(2)-glycoprotein 1 in the diagnosis of antiphospholipid syndrome.

Authors:  M A P Audrain; D El-Kouri; M A Hamidou; L Mioche; A Ibara; M-L Langlois; J-Y Muller
Journal:  Rheumatology (Oxford)       Date:  2002-05       Impact factor: 7.580

3.  Central retinal vein occlusion in a patient on hemodialysis secondary to antiphospholipid syndrome: Case report.

Authors:  Marouane Jabrane; Med Reda Ez-Zahraoui; Ibtissam Hajji; Wafaa Fadili; Abdeljalil Moutaouakil; Inass Laouad
Journal:  Nephrol Ther       Date:  2017-02-08       Impact factor: 0.722

4.  Antiphospholipid syndrome and antiphospholipid antibody profile in patients with retinal vein occlusion.

Authors:  José L Hernández; Iria Sanlés; Rocío Pérez-Montes; Víctor M Martínez-Taboada; José M Olmos; Zaida Salmón; Isabel Sierra; Estefanía Escalante; José J Napal
Journal:  Thromb Res       Date:  2020-04-12       Impact factor: 3.944

5.  UVEITIS TREATED WITH DEXAMETHASONE IMPLANT.

Authors:  Thibaud Mathis; Alessio Cerquaglia; Michel Weber; Rébecca Guillarme-Sallit; Ariane Malclès; Nicolas Voirin; Marion Servant; Aditya Sudhalkar; Alper Bilgic; Philippe Denis; Pascal Sève; Bahram Bodaghi; Laurent Kodjikian
Journal:  Retina       Date:  2021-03-01       Impact factor: 4.256

Review 6.  Systemic Lupus Erythematosus and Antiphospholipid Antibody Syndrome.

Authors:  Maria Kokosi; Boris Lams; Sangita Agarwal
Journal:  Clin Chest Med       Date:  2019-09       Impact factor: 2.878

Review 7.  Ocular manifestations in antiphospholipid syndrome.

Authors:  Gordana Suvajac; Ljudmila Stojanovich; Svetislav Milenkovich
Journal:  Autoimmun Rev       Date:  2006-12-20       Impact factor: 9.754

Review 8.  Antiphospholipid syndrome.

Authors:  Lisa R Sammaritano
Journal:  Best Pract Res Clin Rheumatol       Date:  2019-12-19       Impact factor: 4.098
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.